In Latvia, Borrelia proteins are being studied to improve the vaccine against Lyme disease
Research in Latvia is focused on Borrelia proteins as potential components for enhancing Lyme disease vaccines.
The number of Lyme disease infections has increased. According to statistics, it is almost three times that of last year.
The reported cases of Lyme disease have surged, with statistics showing almost a threefold increase compared to the previous year.